One such concept is the alteration in the transport of brain-derived neurotrophic factor (BDNF) to RGC somata observed in rodent glaucoma models [22], along with evidence showing that intravitreal injections of BDNF can lower the rate of RGC loss [23]. This evidence concerns the gene BDNF and glaucoma.